Create the future of medicine
Campus Berlin-Buch has a new start-up center: The BerlinBioCube was ceremonially opened on October 11, 2023.
New spaces for young companies (start-ups)
The BerlinBioCube offers a total of 8,000 square meters of space on five floors for modern laboratories, offices, and common areas for daily encounters and exchanges as well as conference rooms.
Over the next few weeks, 14 young companies will move into the building, including spin-offs from the Max Delbrück Center, Charité – Universitätsmedizin Berlin, and the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP). These companies are engaged in the development of innovative gene and cell therapies or novel compounds for the effective treatment of cancer and other common diseases.
The building was designed by the Munich-based architectural firm doranth post architekten. Construction began in September 2020. After three years of construction, the BerlinBioCube was completed in October 2023, marking the end of the BiotechPark’s fourth construction phase.
The compact building designed by doranth post architekten makes optimal use of the space it occupies in the BiotechPark. The structuring of the façade and textile elements lend a quality of lightness to the building. The incubator center meets the demands of state-of-the-art research facilities. These include high amenity value, laboratories with daylight, and common areas that foster and encourage communication.
Follow the construction of the BerlinBioCube live!
The BerlinBioCube is being constructed on the Berlin-Buch Campus in the BiotechPark Berlin-Buch, which with 75 companies, 850 employees and around 31,000 square meters of office and laboratory space is one of the leading technology parks in Germany. Spin-offs in the field of life sciences find ideal conditions here, from technology transfer to industry-specific laboratory and office space. The life science community on site facilitates direct exchange and joint projects. The BiotechPark contributes significantly to the dynamic development of the biotechnology region of Berlin-Brandenburg and strengthens the industrial health economy to a great extent.
The construction of the BerlinBioCube involves an investment of 48.9 million euros and is made possible by funding under the Joint Task for the Improvement of Regional Economic Structures (GRW).